The closing price of Herbalife Ltd (NYSE: HLF) was $7.86 for the day, up 2.75% from the previous closing price of $7.65. In other words, the price has increased by $+0.21 from its previous closing price. On the day, 5092832 shares were traded.
Ratios:
Our analysis of HLF’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.51. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, DA Davidson on September 14, 2023, initiated with a Neutral rating and assigned the stock a target price of $13.50.
On June 07, 2023, Mizuho started tracking the stock assigning a Neutral rating and target price of $13.
On February 03, 2023, BofA Securities started tracking the stock assigning a Underperform rating and target price of $14.BofA Securities initiated its Underperform rating on February 03, 2023, with a $14 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 26 ’24 when Mendoza Juan Miguel bought 16,079 shares for $9.40 per share. The transaction valued at 151,143 led to the insider holds 54,622 shares of the business.
Macadrai Rodica bought 5,332 shares of HLF for $50,121 on Mar 26 ’24. The Director now owns 18,048 shares after completing the transaction at $9.40 per share. On Mar 26 ’24, another insider, Wang Henry C, who serves as the EVP, General Counsel of the company, bought 2,778 shares for $9.30 each. As a result, the insider paid 25,835 and bolstered with 176,194 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HLF now has a Market Capitalization of 784.32M and an Enterprise Value of 2.98B. As of this moment, Herbalife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.53, and their Forward P/E ratio for the next fiscal year is 2.93. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.15. Its current Enterprise Value per Revenue stands at 0.59 whereas that against EBITDA is 6.18.
Stock Price History:
Over the past 52 weeks, HLF has reached a high of $19.48, while it has fallen to a 52-week low of $6.68. The 50-Day Moving Average of the stock is 9.75, while the 200-Day Moving Average is calculated to be 13.12.
Shares Statistics:
HLF traded an average of 2.22M shares per day over the past three months and 3.32M shares per day over the past ten days. A total of 99.20M shares are outstanding, with a floating share count of 95.30M. Insiders hold about 3.99% of the company’s shares, while institutions hold 106.08% stake in the company. Shares short for HLF as of Mar 15, 2024 were 13.08M with a Short Ratio of 5.88, compared to 13.13M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 13.11% and a Short% of Float of 16.69%.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 1.70. The current Payout Ratio is 0.00% for HLF, which recently paid a dividend on Mar 18, 2014 with an ex-dividend date of Feb 28, 2014. Stock splits for the company last occurred on May 15, 2018 when the company split stock in a 2:1 ratio.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of $0.34 for the current quarter, with a high estimate of $0.37 and a low estimate of $0.31, while EPS last year was $0.54. The consensus estimate for the next quarter is $0.67, with high estimates of $0.71 and low estimates of $0.63.
Analysts are recommending an EPS of between $2.3 and $1.82 for the fiscal current year, implying an average EPS of $2.06. EPS for the following year is $2.64, with 4 analysts recommending between $2.83 and $2.31.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $1.27B to a low estimate of $1.23B. As of the current estimate, Herbalife Ltd’s year-ago sales were $1.25B, an estimated increase of 0.40% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $1.33B, an increase of 4.10% over than the figure of $0.40% in the same quarter last year. There is a high estimate of $1.35B for the next quarter, whereas the lowest estimate is $1.32B.
A total of 5 analysts have provided revenue estimates for HLF’s current fiscal year. The highest revenue estimate was $5.19B, while the lowest revenue estimate was $5.08B, resulting in an average revenue estimate of $5.12B. In the same quarter a year ago, actual revenue was $5.06B, up 1.20% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $5.35B in the next fiscal year. The high estimate is $5.45B and the low estimate is $5.3B. The average revenue growth estimate for next year is up 4.50% from the average revenue estimate for this year.
